Hialeah, FL

L&A Morales Healthcare, Inc

Lung Diseases

Mycobacterium avium-intracellulare Infection

Epetraborole

AN2 Therapeutics

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR (Optimized Background Regimen) versus placebo + OBR in patients with treatment-refractory MAC lung disease. This study will enroll adult patients with treatment-refractory MAC lung disease who meet all eligibility criteria (including clinical, radiographic, and microbiological criteria).

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

L&A Morales Healthcare, Inc | Hialeah, FL

Site insights

Work at this site?

Active trials

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

Trial sponsors